STAT+: Pharmalittle: We’re reading about Lilly plant problems, FDA reorganization plans, and more
The FDA uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by the agency.
by Ed Silverman
Jan 22, 2024
1 minute
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because now the time has come to dive back in to the usual routine of online meetings,
You’re reading a preview, subscribe to read more.
Start your free 30 days